HENSIFY Trademark

Trademark Overview


On Thursday, May 12, 2016, a trademark application was filed for HENSIFY with the United States Patent and Trademark Office. The USPTO has given the HENSIFY trademark a serial number of 79190033. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, October 24, 2023. This trademark is owned by NANOBIOTIX. The HENSIFY trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products, namely agents for the treatment of tumors in the field of radiation therapy; medicines for humans for the treatment of cancer; health products, namely, pharmaceutical preparations for cancer treatment; preparations for medical use, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use; chemical preparations for medical and pharmaceutical use being drug delivery agents in the form of tablets and capsules for the treatment of cancer; drugs for medical use for the treatment of cancer; chemico-pharmaceutical products being tablets for the treatment of cancer; diagnostic biomarking reagents for medical use

Testing apparatus for medical use, namely medical X-ray apparatus; diagnostic apparatus for medical use, namely medical X-ray apparatus; apparatus for medical use, namely therapeutic mattresses, beds, seats and cushions; screens for medical use
hensify

General Information


Serial Number79190033
Word MarkHENSIFY
Filing DateThursday, May 12, 2016
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, October 24, 2023
Registration Number5173704
Registration DateTuesday, April 4, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2017

Trademark Statements


Goods and ServicesPharmaceutical products, namely agents for the treatment of tumors in the field of radiation therapy; medicines for humans for the treatment of cancer; health products, namely, pharmaceutical preparations for cancer treatment; preparations for medical use, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use; chemical preparations for medical and pharmaceutical use being drug delivery agents in the form of tablets and capsules for the treatment of cancer; drugs for medical use for the treatment of cancer; chemico-pharmaceutical products being tablets for the treatment of cancer; diagnostic biomarking reagents for medical use
Goods and ServicesTesting apparatus for medical use, namely medical X-ray apparatus; diagnostic apparatus for medical use, namely medical X-ray apparatus; apparatus for medical use, namely therapeutic mattresses, beds, seats and cushions; screens for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, August 12, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNANOBIOTIX
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameNANOBIOTIX
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameNANOBIOTIX
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, August 11, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 16, 2016APPLICATION FILING RECEIPT MAILED
Monday, August 29, 2016ASSIGNED TO EXAMINER
Friday, September 2, 2016NON-FINAL ACTION WRITTEN
Saturday, September 3, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 8, 2016REFUSAL PROCESSED BY MPU
Thursday, September 8, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 23, 2016REFUSAL PROCESSED BY IB
Friday, December 9, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 9, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 9, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2016NOTICE OF PUBLICATION
Wednesday, January 11, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 11, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 17, 2017PUBLISHED FOR OPPOSITION
Thursday, January 26, 2017NOTIFICATION PROCESSED BY IB
Tuesday, April 4, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, July 4, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, July 8, 2017FINAL DISPOSITION PROCESSED
Saturday, July 8, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 27, 2023TEAS SECTION 71 RECEIVED
Saturday, October 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 24, 2023REGISTERED-SEC.71 ACCEPTED
Tuesday, October 24, 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, September 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 4, 2026COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED